世界の神経血管デバイス／インターベンショナル神経学市場予測　2023-2032年

REPORT SYNOPSIS

KEY FINDINGS
The global neurovascular devices/interventional neurology market is anticipated to register a CAGR of 5.23% during the forecast period. The market’s growth is attributed to key drivers, such as the rising incidence of neurological conditions across the world, the surging preference for minimally invasive procedures, the geriatric population’s vulnerability to neurovascular diseases, and underlying diseases increasing the risk of neurovascular conditions.

MARKET INSIGHTS
Neurovascular disorders are linked to the blood vessels that supply oxygenated blood to the brain and spinal cord. Any disruption in blood flow can lead to impaired brain function, posing life-threatening risks. Immediate medical attention is essential for these conditions. Factors like intracranial stenosis, high bad cholesterol, hypertension, and diabetes contribute to neurovascular diseases.

For example, elevated bad cholesterol levels can cause plaque deposition in intracranial arteries, leading to stenosis and increasing the risk of ischemic stroke. Prompt treatment using neurovascular devices becomes crucial in managing these conditions, driving the growth of the market. Additionally, hypertension, a major cause of ischemic stroke, can result in blood clots that block arteries supplying the brain, leading to a stroke. As a result, underlying diseases leading to the increased risk of neurovascular conditions are expected to contribute to the global neurovascular devices/interventional neurology market growth during the forecast period.
REGIONAL INSIGHTS
The global neurovascular devices/interventional neurology market growth assessment entails the analysis of Europe, Asia-Pacific, North America, and Rest of World. North America is expected to capture the highest revenue share by 2032, with the region’s growth ascribed to the increase in neurovascular illnesses as well as high investments in cutting-edge medical technologies.
COMPETITIVE INSIGHTS
The industry rivalry is set to increase during the forecasted period as key players in the global neurovascular devices/interventional neurology market implement various strategies to augment their market shares. Accordingly, some of the top companies in the market are Medtronic Inc, Memry Corporation, Penumbra Inc, MicroPort Scientific Corporation, etc.
Our report offerings include:

• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Report Overview Inkwood Researchでは世界の主要地域・国別の市場調査レポートも出版しています。各レポートの詳細についてはChosaReport.comまでお問合せください。

Table of Contents

1. RESEARCH SCOPE & METHODOLOGY
1.1.STUDY OBJECTIVES
1.2.METHODOLOGY
1.3.ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1.MARKET SIZE & ESTIMATES
2.2.MARKET OVERVIEW
2.3.SCOPE OF STUDY
2.4.CRISIS SCENARIO ANALYSIS
2.4.1. IMPACT OF COVID-19 ON NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
2.5.MAJOR MARKET FINDINGS
2.5.1. GOVERNMENT INITIATIVES TO CREATE AWARENESS ABOUT NEUROVASCULAR DISEASES
2.5.2. EARLY DETECTION OF ARTERIOVENOUS MALFORMATION (AVM)
2.5.3. THROMBECTOMY IMPROVES PATIENT OUTCOMES AND REDUCES DISABILITY RATE
3. MARKET DYNAMICS
3.1.KEY DRIVERS
3.1.1. SIGNIFICANT RISE IN INCIDENCE OF NEUROVASCULAR CONDITIONS
3.1.2. PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES
3.1.3. GERIATRIC POPULATION’S VULNERABILITY TO NEUROVASCULAR DISEASES
3.1.4. UNDERLYING DISEASES ARE A RISK FACTOR FOR NEUROVASCULAR DISEASES
3.2.KEY RESTRAINTS
3.2.1. EXORBITANT COSTS OF NEUROVASCULAR DEVICES
3.2.2. LACK OF TRAINED NEUROSURGEONS
4. KEY ANALYTICS
4.1.KEY MARKET TRENDS
4.2.PORTER’S FIVE FORCES ANALYSIS
4.2.1. BUYERS POWER
4.2.2. SUPPLIERS POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3.GROWTH PROSPECT MAPPING
4.3.1. GROWTH PROSPECT MAPPING FOR UNITED STATES
4.3.2. GROWTH PROSPECT MAPPING FOR UNITED KINGDOM
4.3.3. GROWTH PROSPECT MAPPING FOR THAILAND
4.3.4. GROWTH PROSPECT MAPPING FOR MIDDLE EAST & AFRICA
4.4.MARKET MATURITY ANALYSIS
4.5.MARKET CONCENTRATION ANALYSIS
4.6.VALUE CHAIN ANALYSIS
5. MARKET BY PRODUCT
5.1.EMBOLIZATION DEVICES
5.1.1. EMBOLIC COILS
5.1.1.1. COATED DETACHABLE COILS
5.1.1.2. BARE DETACHABLE COILS
5.1.2. COIL ASSIST STENT
5.1.3. CLIPPINGS
5.1.4. COIL ASSIST BALLOON
5.2.ACCESSORY DEVICES
5.2.1. MICROCATHETERS
5.2.2. MICRO GUIDEWIRES
5.3.REVASCULARIZATION DEVICES
5.3.1. CAROTID ARTERY STENTS
5.3.2. FLOW DIVERSION STENTS
5.4.THROMBECTOMY DEVICES
5.4.1. CLOT RETRIEVAL DEVICES
5.4.2. SUCTION AND ASPIRATION DEVICES
5.4.3. SNARES
5.5.EMBOLIC PROTECTION DEVICES
5.5.1. BALLOON OCCLUSION DEVICES
5.5.2. DISTAL FILTER DEVICES
6. MARKET BY APPLICATION
6.1.ANEURYSM
6.2.ISCHEMIC STROKE
6.3.STENOSIS
6.4.ARTERIOVENOUS MALFORMATION (AVM)
6.5.OTHER APPLICATIONS
7. GEOGRAPHICAL ANALYSIS
7.1.NORTH AMERICA
7.1.1. MARKET SIZE & ESTIMATES
7.1.2. NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET DRIVERS
7.1.3. NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET CHALLENGES
7.1.4. NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK
7.1.5. KEY PLAYERS IN NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
7.1.6. COUNTRY ANALYSIS
7.1.6.1. UNITED STATES
7.1.6.1.1. UNITED STATES NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.1.6.2. CANADA
7.1.6.2.1. CANADA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.2.EUROPE
7.2.1. MARKET SIZE & ESTIMATES
7.2.2. EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET DRIVERS
7.2.3. EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET CHALLENGES
7.2.4. EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK
7.2.5. KEY PLAYERS IN EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
7.2.6. COUNTRY ANALYSIS
7.2.6.1. UNITED KINGDOM
7.2.6.1.1. UNITED KINGDOM NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.2.6.2. GERMANY
7.2.6.2.1. GERMANY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.2.6.3. FRANCE
7.2.6.3.1. FRANCE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.2.6.4. ITALY
7.2.6.4.1. ITALY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.2.6.5. SPAIN
7.2.6.5.1. SPAIN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.2.6.6. POLAND
7.2.6.6.1. POLAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.2.6.7. BELGIUM
7.2.6.7.1. BELGIUM NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.2.6.8. REST OF EUROPE
7.2.6.8.1. REST OF EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.3.ASIA-PACIFIC
7.3.1. MARKET SIZE & ESTIMATES
7.3.2. ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET DRIVERS
7.3.3. ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET CHALLENGES
7.3.4. ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK
7.3.5. KEY PLAYERS IN ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
7.3.6. COUNTRY ANALYSIS
7.3.6.1. CHINA
7.3.6.1.1. CHINA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.3.6.2. JAPAN
7.3.6.2.1. JAPAN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.3.6.3. INDIA
7.3.6.3.1. INDIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.3.6.4. SOUTH KOREA
7.3.6.4.1. SOUTH KOREA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.3.6.5. INDONESIA
7.3.6.5.1. INDONESIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.3.6.6. THAILAND
7.3.6.6.1. THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.3.6.7. VIETNAM
7.3.6.7.1. VIETNAM NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.3.6.8. AUSTRALIA & NEW ZEALAND
7.3.6.8.1. AUSTRALIA & NEW ZEALAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.3.6.9. REST OF ASIA-PACIFIC
7.3.6.9.1. REST OF ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.4.REST OF WORLD
7.4.1. MARKET SIZE & ESTIMATES
7.4.2. REST OF WORLD NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET DRIVERS
7.4.3. REST OF WORLD NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET CHALLENGES
7.4.4. REST OF WORLD NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK
7.4.5. KEY PLAYERS IN REST OF WORLD NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
7.4.6. REGIONAL ANALYSIS
7.4.6.1. LATIN AMERICA
7.4.6.1.1. LATIN AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.4.6.2. MIDDLE EAST & AFRICA
7.4.6.2.1. MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
8. COMPETITIVE LANDSCAPE
8.1.KEY STRATEGIC DEVELOPMENTS
8.1.1. MERGERS & ACQUISITIONS
8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIPS & AGREEMENTS
8.1.4. BUSINESS EXPANSIONS & DIVESTITURES
8.2.COMPANY PROFILES
8.2.1. ACANDIS GMBH
8.2.1.1. COMPANY OVERVIEW
8.2.1.2. PRODUCT LIST
8.2.2. ASAHI INTECC
8.2.2.1. COMPANY OVERVIEW
8.2.2.2. PRODUCT LIST
8.2.3. BALT
8.2.3.1. COMPANY OVERVIEW
8.2.3.2. PRODUCT LIST
8.2.4. B BRAUN MELSUNGEN AG
8.2.4.1. COMPANY OVERVIEW
8.2.4.2. PRODUCT LIST
8.2.4.3. STRENGTHS & CHALLENGES
8.2.5. INTEGER HOLDINGS CORPORATION
8.2.5.1. COMPANY OVERVIEW
8.2.5.2. PRODUCT LIST
8.2.5.3. STRENGTHS & CHALLENGES
8.2.6. JOHNSON & JOHNSON (CERENOVUS)
8.2.6.1. COMPANY OVERVIEW
8.2.6.2. PRODUCT LIST
8.2.6.3. STRENGTHS & CHALLENGES
8.2.7. KANEKA CORPORATION
8.2.7.1. COMPANY OVERVIEW
8.2.7.2. PRODUCT LIST
8.2.8. MEDTRONIC INC
8.2.8.1. COMPANY OVERVIEW
8.2.8.2. PRODUCT LIST
8.2.8.3. STRENGTHS & CHALLENGES
8.2.9. MEMRY CORPORATION
8.2.9.1. COMPANY OVERVIEW
8.2.9.2. PRODUCT LIST
8.2.10. MICROPORT SCIENTIFIC CORPORATION
8.2.10.1. COMPANY OVERVIEW
8.2.10.2. PRODUCT LIST
8.2.10.3. STRENGTHS & CHALLENGES
8.2.11. PENUMBRA INC
8.2.11.1. COMPANY OVERVIEW
8.2.11.2. PRODUCT LIST
8.2.12. PHENOX INC
8.2.12.1. COMPANY OVERVIEW
8.2.12.2. PRODUCT LIST
8.2.12.3. STRENGTHS & CHALLENGES
8.2.13. RAPID MEDICAL
8.2.13.1. COMPANY OVERVIEW
8.2.13.2. PRODUCT LIST
8.2.13.3. STRENGTHS & CHALLENGES
8.2.14. SENSOME
8.2.14.1. COMPANY OVERVIEW
8.2.14.2. PRODUCT LIST
8.2.14.3. STRENGTHS & CHALLENGES
8.2.15. STRYKER CORPORATION
8.2.15.1. COMPANY OVERVIEW
8.2.15.2. PRODUCT LIST
8.2.15.3. STRENGTHS & CHALLENGES
8.2.16. TERUMO CORPORATION
8.2.16.1. COMPANY OVERVIEW
8.2.16.2. PRODUCT LIST
8.2.16.3. STRENGTHS & CHALLENGES 
LIST OF TABLES 
TABLE 1: MARKET SNAPSHOT – NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY
TABLE 2: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 3: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 4: GLOBAL EMBOLIZATION DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 5: GLOBAL EMBOLIZATION DEVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 6: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIZATION DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 7: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIZATION DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 8: GLOBAL EMBOLIC COILS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 9: GLOBAL EMBOLIC COILS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 10: GLOBAL EMBOLIZATION DEVICES MARKET, BY EMBOLIC COILS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 11: GLOBAL EMBOLIZATION DEVICES MARKET, BY EMBOLIC COILS, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 12: GLOBAL BARE DETACHABLE COILS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 13: GLOBAL BARE DETACHABLE COILS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 14: GLOBAL COIL ASSIST STENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 15: GLOBAL COIL ASSIST STENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 16: GLOBAL CLIPPINGS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 17: GLOBAL CLIPPINGS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 18: GLOBAL COIL ASSIST BALLOON MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 19: GLOBAL COIL ASSIST BALLOON MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 20: GLOBAL ACCESSORY DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 21: GLOBAL ACCESSORY DEVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 22: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ACCESSORY DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 23: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ACCESSORY DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 24: GLOBAL MICROCATHETERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 25: GLOBAL MICROCATHETERS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 26: GLOBAL MICRO GUIDEWIRES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 27: GLOBAL MICROCATHETERS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 28: GLOBAL REVASCULARIZATION DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 29: GLOBAL REVASCULARIZATION DEVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 30: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REVASCULARIZATION DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 31: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REVASCULARIZATION DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 32: GLOBAL CAROTID ARTERY STENTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 33: GLOBAL CAROTID ARTERY STENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 34: GLOBAL FLOW DIVERSION STENTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 35: GLOBAL FLOW DIVERSION STENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 36: GLOBAL THROMBECTOMY DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 37: GLOBAL THROMBECTOMY DEVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 38: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY THROMBECTOMY DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 39: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY THROMBECTOMY DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 40: GLOBAL CLOT RETRIEVAL DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 41: GLOBAL CLOT RETRIEVAL DEVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 42: GLOBAL SUCTION AND ASPIRATION DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 43: GLOBAL SUCTION AND ASPIRATION DEVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 44: GLOBAL SNARES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 45: GLOBAL SNARES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 46: GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 47: GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 48: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC PROTECTION DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 49: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC PROTECTION DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 50: GLOBAL BALLOON OCCLUSION DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 51: GLOBAL BALLOON OCCLUSION DEVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 52: GLOBAL DISTAL FILTER DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 53: GLOBAL DISTAL FILTER DEVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 54: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 55: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY APPLICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 56: GLOBAL ANEURYSM MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 57: GLOBAL ANEURYSM MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 58: GLOBAL ISCHEMIC STROKE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 59: GLOBAL ISCHEMIC STROKE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 60: GLOBAL STENOSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 61: GLOBAL STENOSIS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 62: GLOBAL ARTERIOVENOUS MALFORMATION (AVM) MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 63: GLOBAL ARTERIOVENOUS MALFORMATION (AVM) MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 64: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 65: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 66: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 67: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 68: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 69: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 70: NORTH AMERICANEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK 
TABLE 71: KEY PLAYERS OPERATING IN NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET 
TABLE 72: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 73: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 74: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK 
TABLE 75: KEY PLAYERS OPERATING IN EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET 
TABLE 76: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 77: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 78: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK 
TABLE 79: KEY PLAYERS OPERATING IN ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET 
TABLE 80: REST OF WORLD NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) 
TABLE 81: REST OF WORLD NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION) 
TABLE 82: REST OF WORLD NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK 
TABLE 83: KEY PLAYERS OPERATING IN REST OF WORLD NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET 
TABLE 84: LIST OF MERGERS & ACQUISITIONS 
TABLE 85: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS 
TABLE 86: LIST OF PARTNERSHIPS & AGREEMENTS 
TABLE 87: LIST OF BUSINESS EXPANSIONS & DIVESTITURES 
 LIST OF FIGURES 
FIGURE 1: KEY MARKET TRENDS 
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS 
FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED STATES 
FIGURE 4: GROWTH PROSPECT MAPPING FOR UNITED KINGDOM 
FIGURE 5: GROWTH PROSPECT MAPPING FOR THAILAND 
FIGURE 6: GROWTH PROSPECT MAPPING FOR MIDDLE EAST & AFRICA 
FIGURE 7: MARKET MATURITY ANALYSIS 
FIGURE 8: MARKET CONCENTRATION ANALYSIS
FIGURE 9: VALUE CHAIN ANALYSIS
FIGURE 10: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2022 
FIGURE 11: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIZATION DEVICES, 2023-2032 (IN $ MILLION)
FIGURE 12: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY EMBOLIZATION DEVICES, IN 2022 
FIGURE 13: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC COILS, 2023-2032 (IN $ MILLION)
FIGURE 14: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY EMBOLIC COILS, IN 2022
FIGURE 15: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COATED DETACHABLE COILS, 2023-2032 (IN $ MILLION) 
FIGURE 16: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY BARE DETACHABLE COILS, 2023-2032 (IN $ MILLION) 
FIGURE 17: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COIL ASSIST STENT, 2023-2032 (IN $ MILLION)
FIGURE 18: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY CLIPPINGS, 2023-2032 (IN $ MILLION) 
FIGURE 19: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COIL ASSIST BALLOON, 2023-2032 (IN $ MILLION)
FIGURE 20: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ACCESSORY DEVICES, 2023-2032 (IN $ MILLION)
FIGURE 21: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY ACCESSORY DEVICES, IN 2022 
FIGURE 22: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY MICROCATHETERS, 2023-2032 (IN $ MILLION) 
FIGURE 23: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY MICRO GUIDEWIRES, 2023-2032 (IN $ MILLION)
FIGURE 24: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REVASCULARIZATION DEVICES, 2023-2032 (IN $ MILLION) 
FIGURE 25: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY REVASCULARIZATION DEVICES, IN 2022 
FIGURE 26: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY CAROTID ARTERY STENTS, 2023-2032 (IN $ MILLION) 
FIGURE 27: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY FLOW DIVERSION STENTS, 2023-2032 (IN $ MILLION) 
FIGURE 28: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY THROMBECTOMY DEVICES, 2023-2032 (IN $ MILLION) 
FIGURE 29: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY THROMBECTOMY DEVICES, IN 2022 
FIGURE 30: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY CLOT RETRIEVAL DEVICES, 2023-2032 (IN $ MILLION) 
FIGURE 31: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY SUCTION AND ASPIRATION DEVICES, 2023-2032 (IN $ MILLION) 
FIGURE 32: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY SNARES, 2023-2032 (IN $ MILLION) 
FIGURE 33: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC PROTECTION DEVICES, 2023-2032 (IN $ MILLION) 
FIGURE 34: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY EMBOLIC PROTECTION DEVICES, IN 2022 
FIGURE 35: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY BALLOON OCCLUSION DEVICES, 2023-2032 (IN $ MILLION) 
FIGURE 36: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY DISTAL FILTER DEVICES, 2023-2032 (IN $ MILLION)
FIGURE 37: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2022
FIGURE 38: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ANEURYSM, 2023-2032 (IN $ MILLION) 
FIGURE 39: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ISCHEMIC STROKE, 2023-2032 (IN $ MILLION)
FIGURE 40: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY STENOSIS, 2023-2032 (IN $ MILLION) 
FIGURE 41: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ARTERIOVENOUS MALFORMATION (AVM), 2023-2032 (IN $ MILLION) 
FIGURE 42: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY OTHER APPLICATIONS, 2023-2032 (IN $ MILLION)
FIGURE 43: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY GEOGRAPHY, 2022 & 2032 (IN %) 
FIGURE 44: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %) 
FIGURE 45: UNITED STATES NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION) 
FIGURE 46: CANADA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION) 
FIGURE 47: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %) 
FIGURE 48: UNITED KINGDOM NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION) 
FIGURE 49: GERMANY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION) 
FIGURE 50: FRANCE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION) 
FIGURE 51: ITALY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION) 
FIGURE 52: SPAIN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION) 
FIGURE 53: POLAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION) 
FIGURE 54: BELGIUM NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION) 
FIGURE 55: REST OF EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION) 
FIGURE 56: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %) 
FIGURE 57: CHINA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION) 
FIGURE 58: JAPAN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION) 
FIGURE 59: INDIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION) 
FIGURE 60: SOUTH KOREA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION) 
FIGURE 61: INDONESIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION) 
FIGURE 62: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION) 
FIGURE 63: VIETNAM NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION) 
FIGURE 64: AUSTRALIA & NEW ZEALAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 65: REST OF ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 66: REST OF WORLD NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, REGIONAL OUTLOOK, 2022 & 2032 (IN %) 
FIGURE 67: LATIN AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 68: MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)